Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim in Pediatric Sarcoma
NCT00035620Phase 2Completed
- Sponsor
- Amgen
- Start
- Apr 2000
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia, sponsored by Amgen. Started Apr 2000; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00035620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035620.